Viewing Study NCT07188558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-02-17 @ 6:09 PM
Study NCT ID: NCT07188558
Status: RECRUITING
Last Update Posted: 2025-12-09
First Post: 2025-09-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Sponsor: Lyell Immunopharma, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Large B-cell Lymphoma View
None Lymphoma, B-Cell View
None Relapsed Non-Hodgkin Lymphoma View
None Refractory Non-Hodgkin Lymphoma View
None Non-Hodgkin Lymphoma View
None Non-Hodgkin Lymphoma Refractory/ Relapsed View
None Diffuse Large B Cell Lymphoma (DLBCL) View
None Diffuse Large B Cell Lymphoma Refractory View
None Diffuse Large B Cell Lymphoma Relapsed View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Non-Hodgkin Lymphoma View
None CAR T-Cell Therapy View
None CD19 View
None CD19/CD20 View
None Large B-cell Lymphoma View